FindTrial
Sign In

Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19)

Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030578
Enrollment
Unknown
Registered
2020-03-08
Start date
2020-03-07
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:Lung rehabilitation training+Conventional treatment
Control group:Conventional treatment

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with new type of coronavirus pneumonia admitted to the designated hospital of Jinan City have the same diagnostic criteria as "Pneumonitis diagnosis and treatment plan for new type of coronavirus infection (latest version) during 2020.02-2020.05

Exclusion criteria

Exclusion criteria: (1) Chronic obstructive pulmonary disease; (2) Cardiorenal insufficiency; (3) Pregnant women

Design outcomes

Primary

MeasureTime frame
Pulmonary function;6 minutes walking distance;The Short Form -36 Healthy Survey;—

Countries

China

Contacts

Public ContactLiu Yi

Shandong Provincial Hospital

15168888626@163.com+86 18660117915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026